Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Staar Surgical Co. (NASDAQ: STAA) was $41.02 for the day, down -12.07% from the previous closing price of $46.65. In other words, the price has decreased by -$12.07 from its previous closing price. On the day, 1.4 million shares were traded. STAA stock price reached its highest trading level at $45.49 during the session, while it also had its lowest trading level at $39.44.
Ratios:
Our analysis of STAA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.22 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 96.52. For the most recent quarter (mrq), Quick Ratio is recorded 5.22 and its Current Ratio is at 5.84. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on March 11, 2024, Upgraded its rating to Buy and sets its target price to $50 from $30 previously.
On December 04, 2023, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $35.Morgan Stanley initiated its Equal-Weight rating on December 04, 2023, with a $35 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 14 ’24 when WEISNER AIMEE S bought 1,750 shares for $38.11 per share. The transaction valued at 66,692 led to the insider holds 10,864 shares of the business.
BROADWOOD PARTNERS, L.P. bought 4,042 shares of STAA for $109,570 on Jan 08 ’24. The 10% Owner now owns 10,768,430 shares after completing the transaction at $27.11 per share. On Jan 05 ’24, another insider, BROADWOOD PARTNERS, L.P., who serves as the 10% Owner of the company, bought 156,734 shares for $28.48 each. As a result, the insider paid 4,463,231 and bolstered with 10,764,388 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STAA now has a Market Capitalization of 2015357696 and an Enterprise Value of 2072057600. As of this moment, Staar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 132.62, and their Forward P/E ratio for the next fiscal year is 49.26. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.18 while its Price-to-Book (P/B) ratio in mrq is 5.13. Its current Enterprise Value per Revenue stands at 6.351 whereas that against EBITDA is 69.376.
Stock Price History:
The Beta on a monthly basis for STAA is 0.68, which has changed by -0.31011534 over the last 52 weeks, in comparison to a change of 0.2537824 over the same period for the S&P500. Over the past 52 weeks, STAA has reached a high of $68.27, while it has fallen to a 52-week low of $26.66. The 50-Day Moving Average of the stock is -1.94%, while the 200-Day Moving Average is calculated to be 6.53%.
Shares Statistics:
STAA traded an average of 685.88K shares per day over the past three months and 479110 shares per day over the past ten days. A total of 48.84M shares are outstanding, with a floating share count of 48.75M. Insiders hold about 0.78% of the company’s shares, while institutions hold 103.04% stake in the company. Shares short for STAA as of 1713139200 were 4874501 with a Short Ratio of 7.11, compared to 1710460800 on 5433126. Therefore, it implies a Short% of Shares Outstanding of 4874501 and a Short% of Float of 20.629998999999998.
Earnings Estimates
The current assessment of Staar Surgical Co. (STAA) involves the perspectives of 9.0 analysts closely monitoring its market dynamics.On average, analysts expect EPS of $0.04 for the current quarter, with a high estimate of $0.11 and a low estimate of -$0.05, while EPS last year was $0.18. The consensus estimate for the next quarter is $0.24, with high estimates of $0.34 and low estimates of $0.19.
Analysts are recommending an EPS of between $0.74 and $0.3 for the fiscal current year, implying an average EPS of $0.58. EPS for the following year is $0.96, with 9.0 analysts recommending between $1.18 and $0.66.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 11 analysts. It ranges from a high estimate of $77.3M to a low estimate of $72M. As of the current estimate, Staar Surgical Co.’s year-ago sales were $66.96MFor the next quarter, 11 analysts are estimating revenue of $95.33M. There is a high estimate of $99.6M for the next quarter, whereas the lowest estimate is $93M.
A total of 13 analysts have provided revenue estimates for STAA’s current fiscal year. The highest revenue estimate was $342.1M, while the lowest revenue estimate was $335.71M, resulting in an average revenue estimate of $338.82M. In the same quarter a year ago, actual revenue was $322.42MBased on 13 analysts’ estimates, the company’s revenue will be $394.41M in the next fiscal year. The high estimate is $404.6M and the low estimate is $386.23M.
